Literature DB >> 1682510

Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma.

T Tokino1, K Matsubara.   

Abstract

The discovery that hepatitis B virus (HBV) integrates into host chromosomes raises the question of whether such viral DNA integration correlates directly with the activation of specific oncogenes or the inactivation of anti-oncogenes. To obtain insight into this problem, we randomly collected HBV integrant samples from different human hepatocellular carcinomas and identified the site of chromosomal integration by using in situ hybridization and/or linkage analysis with the flanking cellular DNAs as probes. Our findings did not specifically identify particular HBV DNA integration sites in chromosomes, although chromosomes 11 and 17 seemed to have more than the average number of integrants.

Entities:  

Mesh:

Year:  1991        PMID: 1682510      PMCID: PMC250761     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Proto-oncogene amplification and human breast tumor phenotype.

Authors:  J Adnane; P Gaudray; M P Simon; J Simony-Lafontaine; P Jeanteur; C Theillet
Journal:  Oncogene       Date:  1989-11       Impact factor: 9.867

2.  A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma.

Authors:  H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

3.  Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors.

Authors:  C Pasquinelli; F Garreau; L Bougueleret; E Cariani; K H Grzeschik; V Thiers; O Croissant; M Hadchouel; P Tiollais; C Bréchot
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Authors:  T Tokino; S Fukushige; T Nakamura; T Nagaya; T Murotsu; K Shiga; N Aoki; K Matsubara
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma.

Authors:  T Nagaya; T Nakamura; T Tokino; T Tsurimoto; M Imai; T Mayumi; K Kamino; K Yamamura; K Matsubara
Journal:  Genes Dev       Date:  1987-10       Impact factor: 11.361

6.  Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene.

Authors:  G Casey; R Smith; D McGillivray; G Peters; C Dickson
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

7.  Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma.

Authors:  Y Z Zhou; B L Slagle; L A Donehower; P vanTuinen; D H Ledbetter; J S Butel
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Identification of a chromosomal aberration associated with a hepatitis B DNA integration site in human cells.

Authors:  A S Henderson; S Ripley; O Hino; C E Rogler
Journal:  Cancer Genet Cytogenet       Date:  1988-02

9.  Identification of a second human retinoic acid receptor.

Authors:  N Brand; M Petkovich; A Krust; P Chambon; H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

10.  Microdeletion associated with the integration process of hepatitis B virus DNA.

Authors:  T Nakamura; T Tokino; T Nagaya; K Matsubara
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

View more
  15 in total

Review 1.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 2.  Update of research and management of hepatitis B.

Authors:  Takeshi Okanoue; Masahito Minami
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

3.  Effects of hepatitis B virus infection on human sperm chromosomes.

Authors:  Jian-Min Huang; Tian-Hua Huang; Huan-Ying Qiu; Xiao-Wu Fang; Tian-Gang Zhuang; Hong-Xi Liu; Yong-Hua Wang; Li-Zhi Deng; Jie-Wen Qiu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas.

Authors:  Y Murakami; K Saigo; H Takashima; M Minami; T Okanoue; C Bréchot; P Paterlini-Bréchot
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

5.  Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors.

Authors:  Y Wei; G Fourel; A Ponzetto; M Silvestro; P Tiollais; M A Buendia
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

Review 6.  Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.

Authors:  Francisco Rodriguez-Frias; Maria Buti; David Tabernero; Maria Homs
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

7.  Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.

Authors:  Dong Ding; Xiaoyan Lou; Dasong Hua; Wei Yu; Lisha Li; Jun Wang; Feng Gao; Na Zhao; Guoping Ren; Lanjuan Li; Biaoyang Lin
Journal:  PLoS Genet       Date:  2012-12-06       Impact factor: 5.917

Review 8.  Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance.

Authors:  Sheng-Han Wang; Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

Review 9.  HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site.

Authors:  Dake Zhang; Ke Zhang; Urlike Protzer; Changqing Zeng
Journal:  J Clin Transl Hepatol       Date:  2021-04-25

Review 10.  Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

Authors:  Drazen B Zimonjic; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2012-05-10       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.